San Diego, CA — August 25, 2025 — Leads & Copy — Fate Therapeutics, Inc. (NASDAQ: FATE) will participate in the Wells Fargo Healthcare Conference on September 3, 2025, in Boston, and the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. A live webcast of each presentation, if recorded, will be available on the company’s website.
Fate Therapeutics is dedicated to developing induced pluripotent stem cell (iPSC)-derived cellular immunotherapies.
Fate Therapeutics is headquartered in San Diego, CA.
Contact: Christina Tartaglia, Precision AQ, 212.362.1200, christina.tartaglia@precisionaq.com
Source: Fate Therapeutics, Inc.
